July 2019

How Real-World Data Can Affect NSCLC Treatment

July 16, 2019

Evidence-Based Oncology

Real-world evidence is being embraced by FDA as a way to expand the review of data beyond the trial population, which may not be representative of the patients seen in clinics on a daily basis.

Policy Updates: ASCO 2019

July 16, 2019

Evidence-Based Oncology

From the Oncology Care Model to the possibilities of cannabis, policy issues drew big crowds at the 2019 Annual Meeting of the American Society of Clinical Oncology.